395 related articles for article (PubMed ID: 30066854)
1. CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.
Liu P; Liang Y; Jiang L; Wang H; Wang S; Dong J
Int J Oncol; 2018 Oct; 53(4):1544-1556. PubMed ID: 30066854
[TBL] [Abstract][Full Text] [Related]
2. ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma.
Sun C; Hu A; Wang S; Tian B; Jiang L; Liang Y; Wang H; Dong J
Int J Oncol; 2020 Jul; 57(1):249-263. PubMed ID: 32319605
[TBL] [Abstract][Full Text] [Related]
3. CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway.
Liu W; Liang Y; Chan Q; Jiang L; Dong J
Oncol Rep; 2019 Mar; 41(3):1911-1917. PubMed ID: 30628679
[TBL] [Abstract][Full Text] [Related]
4. Fractalkine/CX3CL1 in Neoplastic Processes.
Korbecki J; Simińska D; Kojder K; Grochans S; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466280
[TBL] [Abstract][Full Text] [Related]
5. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
6. Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions.
Wang K; Jiang L; Hu A; Sun C; Zhou L; Huang Y; Chen Q; Dong J; Zhou X; Zhang F
Theranostics; 2021; 11(10):4770-4789. PubMed ID: 33754027
[No Abstract] [Full Text] [Related]
7. CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway.
Liang Y; Yi L; Liu P; Jiang L; Wang H; Hu A; Sun C; Dong J
J Cancer; 2018; 9(19):3603-3612. PubMed ID: 30310518
[TBL] [Abstract][Full Text] [Related]
8. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.
Poniatowski ŁA; Wojdasiewicz P; Krawczyk M; Szukiewicz D; Gasik R; Kubaszewski Ł; Kurkowska-Jastrzębska I
Mol Neurobiol; 2017 Apr; 54(3):2167-2188. PubMed ID: 26927660
[TBL] [Abstract][Full Text] [Related]
10. CX3CL1 in the red bone marrow promotes renal cell carcinoma to metastasize to the spine by involving the Src-related pathway.
Hu AN; Chen FC; Wang KT; Wang ZQ; Liang Y; Dong J
Neoplasma; 2022 May; 69(3):670-679. PubMed ID: 35330998
[TBL] [Abstract][Full Text] [Related]
11. Role of the CX
Hamdan D; Robinson LA
Am J Physiol Renal Physiol; 2021 Aug; 321(2):F121-F134. PubMed ID: 34121453
[TBL] [Abstract][Full Text] [Related]
12. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
[TBL] [Abstract][Full Text] [Related]
13. CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.
Wu XM; Liu Y; Qian ZM; Luo QQ; Ke Y
Mol Neurobiol; 2016 Aug; 53(6):4010-4018. PubMed ID: 26189830
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model.
Seo Y; Kim HS; Kang I; Choi SW; Shin TH; Shin JH; Lee BC; Lee JY; Kim JJ; Kook MG; Kang KS
Glia; 2016 Dec; 64(12):2291-2305. PubMed ID: 27687148
[TBL] [Abstract][Full Text] [Related]
15. The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice.
Yu YW; Li MX; Zhang ZY; Yu H
Int J Mol Med; 2018 Jun; 41(6):3577-3585. PubMed ID: 29568873
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine/CX3CR1 is involved in the pathogenesis of endometriosis by regulating endometrial stromal cell proliferation and invasion.
Hou XX; Zhou WJ; Wang XQ; Li DJ
Am J Reprod Immunol; 2016 Oct; 76(4):318-25. PubMed ID: 27553970
[TBL] [Abstract][Full Text] [Related]
17. CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts.
Hou SM; Hou CH; Liu JF
Arthritis Res Ther; 2017 Dec; 19(1):282. PubMed ID: 29268768
[TBL] [Abstract][Full Text] [Related]
18. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
[TBL] [Abstract][Full Text] [Related]
20. CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism.
Jamieson WL; Shimizu S; D'Ambrosio JA; Meucci O; Fatatis A
Cancer Res; 2008 Mar; 68(6):1715-22. PubMed ID: 18339851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
